| Stage | CON | % of rev | DAL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $622M | 100.00% | $20.2B | 100.00% | DAL ×32.45 |
| Gross profit | $195M | 31.42% | $5.6B | 27.86% | CON +3.6pp |
| Operating income | $115M | 18.52% | $1.5B | 7.20% | CON +11.3pp |
| Pre-tax income | $90M | 14.47% | $1.1B | 5.32% | CON +9.2pp |
| Net income | $68M | 10.89% | $756M | 3.75% | CON +7.1pp |
| Stage | CON | DAL | Gap · A − B |
|---|---|---|---|
| Revenue | $622M100.00% | $20.2B100.00% | DAL ×32.45 |
| Gross profit | 31.42%$195M | 27.86%$5.6B | CON +3.6pp |
| Operating income | 18.52%$115M | 7.20%$1.5B | CON +11.3pp |
| Pre-tax income | 14.47%$90M | 5.32%$1.1B | CON +9.2pp |
| Net income |
| 10.89%$68M |
| 3.75%$756M |
| CON +7.1pp |
No shared counterparties.